Creative Planning Baxter International Inc Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

A detailed history of Creative Planning transactions in Baxter International Inc stock. As of the latest transaction made, Creative Planning holds 91,742 shares of BAX stock, worth $2.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,742
Previous 80,966 13.31%
Holding current value
$2.71 Million
Previous $2.71 Million 28.62%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
BUY
$32.85 - $40.26 $353,991 - $433,841
10,776 Added 13.31%
91,742 $3.48 Million
Q2 2024

Aug 15, 2024
SELL
$32.87 - $43.55 $162,016 - $214,657
-4,929 Reduced 5.74%
80,966 $2.71 Million
Q1 2024

May 10, 2024
BUY
$37.88 - $43.77 $425,884 - $492,106
11,243 Added 15.06%
85,895 $3.67 Million
Q4 2023

Feb 14, 2024
SELL
$31.71 - $38.95 $138,160 - $169,705
-4,357 Reduced 5.51%
74,652 $2.89 Million
Q3 2023

Nov 16, 2023
SELL
$37.32 - $49.29 $321,325 - $424,386
-8,610 Reduced 9.83%
79,009 $2.98 Million
Q2 2023

Jul 21, 2023
SELL
$39.98 - $47.68 $333,193 - $397,365
-8,334 Reduced 8.69%
87,619 $3.99 Million
Q1 2023

May 15, 2023
BUY
$37.58 - $52.57 $1.04 Million - $1.45 Million
27,665 Added 40.51%
95,953 $3.89 Million
Q4 2022

Feb 10, 2023
BUY
$49.7 - $57.71 $15,158 - $17,601
305 Added 0.45%
68,288 $3.48 Million
Q3 2022

Nov 03, 2022
BUY
$53.86 - $66.8 $182,369 - $226,184
3,386 Added 5.24%
67,983 $3.66 Million
Q2 2022

Aug 15, 2022
SELL
$63.83 - $80.0 $92,298 - $115,680
-1,446 Reduced 2.19%
64,597 $4.15 Million
Q1 2022

May 16, 2022
BUY
$76.85 - $89.45 $151,625 - $176,484
1,973 Added 3.08%
66,043 $5.12 Million
Q4 2021

Feb 11, 2022
BUY
$74.57 - $87.19 $57,269 - $66,961
768 Added 1.21%
64,070 $5.5 Million
Q3 2021

Nov 10, 2021
SELL
$73.77 - $83.61 $169,892 - $192,553
-2,303 Reduced 3.51%
63,302 $5.09 Million
Q2 2021

Aug 04, 2021
SELL
$80.5 - $88.01 $1,851 - $2,024
-23 Reduced 0.04%
65,605 $5.28 Million
Q1 2021

Apr 30, 2021
SELL
$76.38 - $86.03 $105,175 - $118,463
-1,377 Reduced 2.06%
65,628 $5.54 Million
Q4 2020

Jan 29, 2021
BUY
$75.39 - $82.36 $179,277 - $195,852
2,378 Added 3.68%
67,005 $5.38 Million
Q3 2020

Nov 05, 2020
BUY
$78.33 - $90.73 $562,957 - $652,076
7,187 Added 12.51%
64,627 $5.2 Million
Q2 2020

Jul 23, 2020
BUY
$78.66 - $94.14 $145,599 - $174,253
1,851 Added 3.33%
57,440 $4.95 Million
Q1 2020

May 05, 2020
BUY
$71.57 - $93.3 $67,633 - $88,168
945 Added 1.73%
55,589 $4.51 Million
Q4 2019

Jan 30, 2020
BUY
$76.7 - $88.45 $224,117 - $258,450
2,922 Added 5.65%
54,644 $4.57 Million
Q3 2019

Nov 01, 2019
SELL
$81.4 - $89.78 $2.96 Million - $3.27 Million
-36,385 Reduced 41.3%
51,722 $4.52 Million
Q2 2019

Jul 26, 2019
BUY
$73.44 - $82.41 $2.78 Million - $3.12 Million
37,855 Added 75.33%
88,107 $7.22 Million
Q1 2019

Apr 24, 2019
SELL
$64.48 - $81.31 $186,863 - $235,636
-2,898 Reduced 5.45%
50,252 $4.09 Million
Q4 2018

Feb 01, 2019
BUY
$61.45 - $77.8 $95,001 - $120,278
1,546 Added 3.0%
53,150 $3.5 Million
Q3 2018

Oct 25, 2018
BUY
$70.71 - $77.75 $234,332 - $257,663
3,314 Added 6.86%
51,604 $3.98 Million
Q2 2018

Jul 20, 2018
BUY
$63.43 - $75.41 $164,473 - $195,538
2,593 Added 5.67%
48,290 $3.57 Million
Q1 2018

Apr 18, 2018
BUY
$62.56 - $72.26 $264,816 - $305,876
4,233 Added 10.21%
45,697 $2.97 Million
Q4 2017

Jan 17, 2018
BUY
$61.45 - $66.05 $157,127 - $168,889
2,557 Added 6.57%
41,464 $2.68 Million
Q3 2017

Oct 17, 2017
BUY
$59.5 - $64.61 $2.31 Million - $2.51 Million
38,907
38,907 $2.44 Million

Others Institutions Holding BAX

# of Institutions
1,007
Shares Held
450M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email